CapCell Biologics Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 3

CapCell Biologics General Information

Description

Developer of advanced drug delivery therapy enzyme replacement using carbon nanotube capsules. The company's technology allows implantation of biologic particles in the patient's body through outpatient procedure, enabling doctors to serve patients with diabetes, cancer, other rare diseases more effectively.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Primary Office
  • 232 Meserole Street
  • Suite 20
  • New York, NY 11206
  • United States

CapCell Biologics Timeline

201820192020
Date FoundedFinancing RoundFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CapCell Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC Completed Stealth
2. Grant 08-Apr-2019 0000 Completed Startup
1. Accelerator/Incubator 08-Jan-2019 Completed Stealth
To view CapCell Biologics’s complete valuation and funding history, request access »

CapCell Biologics Executive Team (2)

Name Title Board Seat Contact Info
Benjamin Young Co-Founder & Chief Executive Officer
Jonathan Zaikowski Co-Founder & President
To view CapCell Biologics’s complete executive team members history, request access »

CapCell Biologics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Columbia Venture Competition University 000 0000 000000 0
Founder Institute Accelerator/Incubator 000 0000 000000 0
Loyal VC Venture Capital Minority 000 0000 000000 0
To view CapCell Biologics’s complete investors history, request access »